4 completed. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
Follow Seneque SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults. Nicotinamide mononucleotide (NMN-C) - Healthy Volunteers | Not applicable | Completed | Seneque SA | 24 | 2021-08-05 | 2023-03-30 |
| Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults Nicotinamide mononucleotide (NMN-C) - Healthy Volunteers | Not applicable | Completed | Seneque SA | 17 | 2021-04-26 | 2023-01-26 |
| Effect of NMN on Muscle Recovery and Physical Capacity in Healthy Volunteers With Moderate Physical Activity Nicotinamide mononucleotide, Placebo - Physical Activity, Muscle Recovery | Not applicable | Completed | Seneque SA | 131 | 2021-03-09 | 2024-01-17 |
| Anti-ageing Efficacy of a Cosmetic Formulation Containing NMN (2%) Versus Placebo Test product creme, Reference creme - Wrinkle, Fatigue | Completed | Seneque SA | 89 | 2020-12-12 | 2021-04-23 |
Fatigue (1) · Motor Activity (1) · Myalgia (1)
Nicotinamide Mononucleotide (3)
France (2) · Canada (1) · China (1) · United States (1)